RODINO-KLAPAC LOUISE (Chief Scientific Officer) reported 2 transactions at SAREPTA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/11/2026ACC: 0001193125-26-102703
Officer· Chief Scientific Officer
Since Dec 2020
-1.40K
Net shares
Net seller
$23.7K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
1.40K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−504.00
Price / share
$16.95
Trade value
$8.54K
% of position
0.2%
3/9/2026
227.67K→227.17K
Common Stock
Direct
Shares
−895.00
Price / share
$16.95
Trade value
$15.17K
% of position
0.4%
3/9/2026
227.17K→226.27K
Total
Net shares
−1.40K
Net value
-$23.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/9/2026 | F · Tax Withholding | −504.00 | $16.95 | $8.54K | 0.2% | 227.67K | 227.17K |
| Common Stock Direct | 3/9/2026 | F · Tax Withholding | −895.00 | $16.95 | $15.17K | 0.4% | 227.17K | 226.27K |
| Total | −1.40K | -$23.71K | ||||||
Derivative Transactions0
No derivative transactions reported